As health insurance companies pull back on their coverage, R.I. needs to look for ways to buy in bulk and adopt a new health strategy, write doctors at the Rhode Island Public Health Institute.

Pfizer is suing over some unsolicited competition in its nearly $5 billion bid to buy the drugmaker Metsera. New York-based Pfizer said Friday after markets closed that it was suing Metsera and ...

Semaglutide appears to safeguard the heart even when patients lose little weight. In a massive international trial, heart attack and stroke risk dropped by 20% regardless of BMI. The benefit seems ...

JCPenney and Ashley Graham defy the Ozempic trend with a bold, size-inclusive campaign that celebrates curves and drives ...

Wearing a sage-coloured gown and clutching a bouquet of white roses and eucalyptus, Sophie Hinchliffe gazed adoringly at the ...

The Wegovy and Ozempic maker’s offer comes after Pfizer last month agreed to a lower deal to acquire the Nasdaq-listed ...

According to new survey data from Gallup, for the first time in years, there’s a significant drop in obesity rates. The percentage of obese Americans has apparently dropped from 39.9% in 2022 to 37% ...

Federal layoffs and government shutdown concerns are compounding worker anxieties about employment stability across public ...